• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment and Long-term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.

作者信息

Recht Abram, Rakovitch Eileen, Solin Lawrence J

机构信息

Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts2Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts.

Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada4Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.

出版信息

JAMA Oncol. 2016 Mar;2(3):396. doi: 10.1001/jamaoncol.2015.4854.

DOI:10.1001/jamaoncol.2015.4854
PMID:26967178
Abstract
摘要

相似文献

1
Treatment and Long-term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.导管原位癌患者的治疗及长期风险
JAMA Oncol. 2016 Mar;2(3):396. doi: 10.1001/jamaoncol.2015.4854.
2
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.导管原位癌患者的治疗及长期风险
JAMA Oncol. 2016 Mar;2(3):395. doi: 10.1001/jamaoncol.2015.4846.
3
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.导管原位癌患者的治疗及长期风险
JAMA Oncol. 2016 Mar;2(3):397-8. doi: 10.1001/jamaoncol.2015.4860.
4
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.导管原位癌患者的治疗及长期风险
JAMA Oncol. 2016 Mar;2(3):398-9. doi: 10.1001/jamaoncol.2015.4866.
5
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.导管原位癌患者的治疗及长期风险
JAMA Oncol. 2016 Mar;2(3):399. doi: 10.1001/jamaoncol.2015.4872.
6
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.导管原位癌患者的治疗及长期风险
JAMA Oncol. 2016 Mar;2(3):399-400. doi: 10.1001/jamaoncol.2015.4875.
7
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ-Reply.导管原位癌患者的治疗及长期风险——回复
JAMA Oncol. 2016 Mar;2(3):395-6. doi: 10.1001/jamaoncol.2015.4840.
8
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ-Reply.导管原位癌患者的治疗及长期风险——回复
JAMA Oncol. 2016 Mar;2(3):400-1. doi: 10.1001/jamaoncol.2015.4878.
9
Treatment Recommendations for Patients With a Diagnosis of Ductal Carcinoma In Situ.导管原位癌患者的治疗建议
JAMA Oncol. 2016 Mar;2(3):398. doi: 10.1001/jamaoncol.2015.4863.
10
Rethinking the Standard for Ductal Carcinoma In Situ Treatment.重新思考导管原位癌的治疗标准
JAMA Oncol. 2015 Oct;1(7):881-3. doi: 10.1001/jamaoncol.2015.2607.

引用本文的文献

1
Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort study.导管原位癌的临床病理特征及后续浸润性乳腺癌的风险：一项基于人群的多中心队列研究
Breast Cancer Res Treat. 2025 Apr;210(3):615-625. doi: 10.1007/s10549-024-07599-x. Epub 2025 Jan 20.
2
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study.基于人群队列研究的原位导管癌女性后续浸润性乳腺癌风险的分子标志物：研究方案。
BMJ Open. 2021 Oct 26;11(10):e053397. doi: 10.1136/bmjopen-2021-053397.
3
Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers.
导管原位癌的放射治疗与第二非乳腺癌风险。
Breast Cancer Res Treat. 2017 Nov;166(1):299-306. doi: 10.1007/s10549-017-4410-6. Epub 2017 Jul 25.
4
Evolution of Premalignant Disease.癌前疾病的演变。
Cold Spring Harb Perspect Med. 2017 Dec 1;7(12):a026542. doi: 10.1101/cshperspect.a026542.